{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:24:04Z","timestamp":1794608644042,"version":"4.9.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long-term effects and side effects of cross-sex hormone treatment in transsexual persons are not well known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study is to describe the effects and side effects of cross-sex hormone therapy in both transsexual men and women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Hormone levels were measured by immunoassays. Physical health was assessed by physical examination and questionnaires on general health and specific side effects, areal bone parameters by dual energy X-ray absorptiometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single center cross-sectional study in 100 transsexual persons post-sex reassignment surgery and on average 10 years on cross-sex hormone therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Transsexual men did not experience important side effects such as cardiovascular events, hormone-related cancers, or osteoporosis. In contrast, a quarter of the transsexual women had osteoporosis at the lumbar spine and radius. Moreover, 6% of transsexual women experienced a thromboembolic event and another 6% experienced other cardiovascular problems after on average 11.3 hormone treatment years. None of the transsexual women experienced a hormone-related cancer during treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cross-sex hormone treatment appears to be safe in transsexual men. On the other hand, a substantial number of transsexual women suffered from osteoporosis at the lumbar spine and distal arm. Twelve percent of transsexual women experienced thromboembolic and\/or other cardiovascular events during hormone treatment, possibly related to older age, estrogen treatment, and lifestyle factors. In order to decrease cardiovascular morbidity, more attention should be paid to decrease cardiovascular risk factors during hormone therapy management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2012.02876.x","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T14:25:27Z","timestamp":1345472727000},"page":"2641-2651","source":"Crossref","is-referenced-by-count":284,"title":["Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons"],"prefix":"10.1093","volume":"9","author":[{"given":"Katrien","family":"Wierckx","sequence":"first","affiliation":[{"name":"Department of Endocrinology, University Hospital Ghent , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Experimental-Clinical and Health Psychology, Ghent University , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Weyers","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, University Hospital Ghent , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Van Caenegem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Ghent , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Roef","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Ghent , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Heylens","sequence":"additional","affiliation":[{"name":"Department of Sexology and Gender Problems, University Hospital Ghent , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"T\u2019Sjoen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Ghent , Ghent , Belgium"},{"name":"Department of Sexology and Gender Problems, University Hospital Ghent , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,1]]},"reference":[{"key":"2024032600343999700_bb0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10508-005-7926-5","article-title":"Sexual and physical health after sex reassignment surgery","volume":"34","author":"De Cuypere","year":"2005","journal-title":"Arch Sex Behav"},{"key":"2024032600343999700_bb0015","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0020","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","article-title":"Endocrine treatment of transsexual people. A review of treatment regimes, outcomes and adverse effects","volume":"88","author":"Moore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4158\/EP.9.1.12","article-title":"Endocrinologic treatment of gender identity disorders","volume":"9","author":"Tangpricha","year":"2003","journal-title":"Endocr Pract"},{"issue":"2","key":"2024032600343999700_bb0030","first-page":"31","article-title":"Hormone treatment of the adult transsexual patient","volume":"64","author":"Gooren","year":"2005","journal-title":"Horm Res"},{"key":"2024032600343999700_bb0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1743-6109.2007.00646.x","article-title":"Review of studies of androgen treatment of female-to-male transsexuals: Effects and risks of administration of androgens to females","volume":"5","author":"Gooren","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600343999700_bb0040","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Care of transsexual persons","volume":"364","author":"Gooren","year":"2011","journal-title":"N Engl J Med"},{"key":"2024032600343999700_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: Extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0050","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1743-6109.2008.01082.x","article-title":"Long-term assessment of the physical, mental and sexual health among transsexual women","volume":"6","author":"Weyers","year":"2009","journal-title":"J Sex Med"},{"key":"2024032600343999700_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jocd.2008.11.002","article-title":"Prevalence of low bone mass in relation to estrogen treatment and body composition in male-to-female transsexual persons","volume":"12","author":"T\u2019Sjoen","year":"2009","journal-title":"J Clin Densitom"},{"key":"2024032600343999700_bb0060","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/j.1743-6109.2011.02348.x","article-title":"Quality of life and sexual health after sex reassignment surgery in transsexual men","volume":"8","author":"Wierckx","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600343999700_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-11-0250","article-title":"Sexual desire in female-to-male transsexual persons: An exploration of the role of testosterone replacement","volume":"165","author":"Wierckx","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2024032600343999700_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humrep\/der406","article-title":"Reproductive wish in transsexual men","volume":"27","author":"Wierckx","year":"2012","journal-title":"Hum Reprod"},{"key":"2024032600343999700_bb0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults","volume":"8","author":"Looker","year":"1998","journal-title":"Osteoporos Int"},{"key":"2024032600343999700_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2265.2004.02117.x","article-title":"Assessment of the role of 17 beta-oestradiol in bone metabolism in men: Does the assay technique matter? The MINOS study","volume":"61","author":"Szulc","year":"2001","journal-title":"Clin Endodocrinol"},{"key":"2024032600343999700_bb0085","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"Van Kesteren","year":"1997","journal-title":"Clin Endocrinol"},{"key":"2024032600343999700_bb0095","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1111\/j.1743-6109.2010.01962.x","article-title":"Safety of physiological testosterone therapy in women: Lessons from female-to-male transsexuals (FTM) treated with pharmacological testosterone therapy","volume":"7","author":"Traish","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600343999700_bb0100","first-page":"3469","article-title":"Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men","volume":"84","author":"Dobs","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0105","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2007-1692","article-title":"Effects of graded doses of testosterone on erythropoiesis in healthy young and older men","volume":"93","author":"Coviello","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2458-7-23","article-title":"Socio-economic and lifestyle factors associated with overweight in Flemisch adult men and women","volume":"7","author":"Duvigneaud","year":"2007","journal-title":"BMC Public Health"},{"key":"2024032600343999700_bb0115","author":"Belgische Gezondheidenqu\u00eate","year":"2008","journal-title":"Rapport 2- leefstijl en preventie"},{"key":"2024032600343999700_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1001293","article-title":"Prevalence of hypertension in the adult population of Belgium: Report of a worksite study","volume":"16","author":"Duprez","year":"2002","journal-title":"J Hum Hypertens"},{"key":"2024032600343999700_bb0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/204748730000700508","article-title":"Trends and regional differences in coronary risk factors in two areas in Belgium: Final results from the MONICA Ghent-Charleroi Study","volume":"7","author":"De Henauw","year":"2000","journal-title":"J Cardiovasc Risk"},{"key":"2024032600343999700_bb0130","first-page":"135","article-title":"Distribution of cardiovascular risk factors in Belgian army men","volume":"65","author":"Mullie","year":"2010","journal-title":"Arch Environ Contam Toxicol"},{"key":"2024032600343999700_bb0135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2024032600343999700_bb0140","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"2024032600343999700_bb0145","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: Systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"2024032600343999700_bb0150","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestagens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"2024032600343999700_bb0155","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex treatment in transsexual people","volume":"88","author":"Toorians","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0160","first-page":"813","article-title":"The incidence of stroke and transient ischaemic attacks is falling: A report from the Belgian sentinel stations","volume":"52","author":"Buntinx","year":"2002","journal-title":"Br J Gen Pract"},{"key":"2024032600343999700_bb0165","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: Oral contraceptives and the risk of ischemic stroke","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"2024032600343999700_bb0170","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/eurheartj\/ehn299","article-title":"Association between hormone replacement therapy and subsequent arterial and venous vascular events: A meta-analysis","volume":"29","author":"Sare","year":"2008","journal-title":"Eur Heart J"},{"key":"2024032600343999700_bb0175","first-page":"1468","article-title":"Life style factors and risk of cerebrovascular disease in women","volume":"24","author":"Lindenstr\u00f8m","year":"1993","journal-title":"Copenhagen City Heart Study Stroke"},{"key":"2024032600343999700_bb0180","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender treatment","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metabolism"},{"key":"2024032600343999700_bb0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/bjs.1800820319","article-title":"Breast cancer in a trans-sexual man receiving hormone replacement therapy","volume":"82","author":"Ganly","year":"1995","journal-title":"Br J Surg"},{"key":"2024032600343999700_bb0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/gyno.1999.5720","article-title":"Ovarian cancer in female-to-male transsexuals: Report of two cases","volume":"76","author":"Hage","year":"2000","journal-title":"Gyanecol Oncol"},{"key":"2024032600343999700_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-08-0289","article-title":"Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones","volume":"159","author":"Mueller","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2024032600343999700_bb0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2008.06.016","article-title":"Clinical and transvaginal sonographic evaluation of the prostate in transsexual women","volume":"74","author":"Weyers","year":"2009","journal-title":"Urology"},{"key":"2024032600343999700_bb0205","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","article-title":"Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist","volume":"113","author":"Dittrich","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2024032600343999700_bb0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00198-004-1754-7","article-title":"Cortical and trabecular BMD in transsexuals after long-term cross-sex hormone treatment: A cross-sectional study","volume":"16","author":"Ruetsche","year":"2005","journal-title":"Osteoporos Int"},{"key":"2024032600343999700_bb0215","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02125.x","article-title":"Testosterone increases bone mineral density in female-to-male transsexuals: A case series of 15 subjects","volume":"61","author":"Turner","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032600343999700_bb0220","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","article-title":"Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals","volume":"7","author":"Mueller","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600343999700_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2265.1998.00396.x","article-title":"Long-term follow up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones","volume":"48","author":"Van Kesteren","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032600343999700_bb0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.1.01943","article-title":"High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone antagonist in the absence of testosterone","volume":"153","author":"Mueller","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2024032600343999700_bb0235","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.5650040503","article-title":"The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals","volume":"4","author":"Lips","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024032600343999700_bb0240","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yhbeh.2007.05.012","article-title":"Cross-sex pattern of bone mineral density in early onset gender identity disorder","volume":"52","author":"Haraldsen","year":"2007","journal-title":"Horm Behav"},{"key":"2024032600343999700_bb0245","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1385\/JCD:6:3:297","article-title":"Bone mass, bone turnover, vitamin D and estrogen receptor gene polymorphism in male-to-female transsexuals: Effect of estrogenic treatment on bone metabolism of the male","volume":"6","author":"Sosa","year":"2003","journal-title":"J Clin Densitom"},{"key":"2024032600343999700_bb0250","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bone.2008.09.001","article-title":"Body composition, volumetric and areal bone parameters in male-to-female transsexual persons","volume":"43","author":"Lapauw","year":"2008","journal-title":"Bone"},{"key":"2024032600343999700_bb0255","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0260","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: Recommendations for diagnosis and therapies","volume":"100","author":"Diamond","year":"2003","journal-title":"Cancer"},{"key":"2024032600343999700_bb0265","first-page":"1633","article-title":"Risk of fracture after androgen deprivation therapy for prostate cancer","volume":"104","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"2024032600343999700_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(05)00033-9","article-title":"Risk of clinical fracture after gonadotropin-releasing hormone agonist therapy for prostate cancer","volume":"175","author":"Smith","year":"2006","journal-title":"J Urol"},{"key":"2024032600343999700_bb0275","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1210\/jc.2011-1540","article-title":"Clinical review: Ethical and medical considerations of androgen deprivation treatment of sex offenders","volume":"96","author":"Gooren","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600343999700_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1479-5868-6-21","article-title":"The international prevalence study on physical activity: Results from 20 countries","volume":"6","author":"Bauman","year":"2009","journal-title":"Int J Behav Nutr Phys Act"},{"key":"2024032600343999700_bb0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10389-006-0031-y","article-title":"Health-enhancing physical activity across European Union countries: The Eurobarometer study","volume":"14","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"J Public Health"},{"key":"2024032600343999700_bb0290","author":"Currie","year":"2004","journal-title":"Young People\u2019s Health in Context: International report from the HBSC 2001\/02 survey"},{"key":"2024032600343999700_bb0295","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1743-6109.2010.02142.x","article-title":"Age of onset and sexual orientation in transsexual males and females","volume":"8","author":"Nieder","year":"2011","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/10\/2641\/47770389\/jsm_9_10_2641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/10\/2641\/47770389\/jsm_9_10_2641.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T21:28:36Z","timestamp":1711402116000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/10\/2641\/6886860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,1]]},"published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02876.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,10]]},"published":{"date-parts":[[2012,10,1]]}}}